Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Pharmacology

• Publication date

  2008-07-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2008.03.046PMID 18565508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The serotonin1A receptor agonist 8-OHDPAT reverses Δ9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats

  2009cited by this paper
• Strain differences in basal and post‐citalopram extracellular 5‐HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase‐2 activity

  2007cited by this paper
• Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.

  2006cited by this paper
• Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice.

  2005cited by this paper
• Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice

  2005cited by this paper
• A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.

  2005cited by this paper
• Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.

  2005cited by this paper
• Genotype-Dependent Activity of Tryptophan Hydroxylase-2 Determines the Response to Citalopram in a Mouse Model of Depression

  2005cited by this paper
• Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims

  2004cited by this paper
• 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.

  2004cited by this paper
• CB1 receptor mediation of cannabinoid behavioral effects in male and female rats

  2004cited by this paper
• Is the forced swimming test a suitable model for revealing antidepressant activity?

  2004cited by this paper
• Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use.

  2004cited by this paper
• New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.

  2004cited by this paper
• CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.

  2004cited by this paper
• Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task.

  2004cited by this paper
• The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

  2003cited by this paper
• Antidepressant-like effects in various mice strains in the forced swimming test

  2003cited by this paper
• Marijuana use and the risk of Major Depressive Episode

  2002cited by this paper
• Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory.

  2002cited by this paper
• Modulation of transmitter release via presynaptic cannabinoid receptors.

  2001cited by this paper
• Cannabis abuse as a risk factor for depressive symptoms.

  2001cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Modulation of Δ9‐tetrahydrocannabinol‐induced hypothermia by fluoxetine in the rat

  1998cited by this paper
• Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat.

  1998cited by this paper
• Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.

  1998cited by this paper
• Angiotensin, LDL peroxidation and atherosclerosis.

  1998cited by this paper
• Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression

  1997cited by this paper
• Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.

  1997cited by this paper
• The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test.

  1996cited by this paper
• Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.

  1995cited by this paper
• A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.

  1995cited by this paper
• Mediation of the antidepressant‐like effect of 8‐OH‐DPAT in mice by postsynaptic 5‐HT1A receptors

  1993cited by this paper
• Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis.

  1991cited by this paper
• Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats

  1986cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

  1985cited by this paper
• ANTAGONISM OF THE EFFECTS ON THERMOREGULATION OF Δ9‐TETRAHYDROCANNABINOL BY CLOMIPRAMINE IN THE RAT

  1978cited by this paper
• Behavioral despair in mice: a primary screening test for antidepressants.

  1977cited by this paper

• Modulatory effects of cannabinoids on brain neurotransmission

  2019cites this paper
• New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders

  2018cites this paper
• Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid‐induced effects

  2018cites this paper
• Cannabinoid-induced lower lip retraction in rats

  2018cites this paper
• Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization

  2017cites this paper
• Involvement of opioid system in antidepressant‐like effect of the cannabinoid CB1 receptor inverse agonist AM‐251 after physical stress in mice

  2016cites this paper
• Effects of Δ9-Tetrahydrocannabinol, Synthetic Cannabinoids, and Fatty Acid Amide Hydrolase Inhibitors on Mood and Serotonin Neurotransmission

  2016cites this paper
• Effects of Cannabinoid and Trpv1 in Formalin-induced Orofacial Pain

  2016cites this paper
• Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor

  2016cites this paper
• Système endocannabinoïde et exercice – implications neuro-métaboliques☆

  2015cites this paper
• Endocannabinoid signaling in the etiology and treatment of major depressive illness.

  2014cites this paper
• The Endocannabinoid/Endovanilloid System and Depression

  2014cites this paper
• The behavioral effects of acute Δ⁹-tetrahydrocannabinol and heroin (diacetylmorphine) exposure in adult zebrafish.

  2014cites this paper
• Behavioral and biochemical effects of Cannabis Sativa and their modulation by antidepressant drugs

  2013influential citation
• BEHAVIORAL AND BIOCHEMICAL EFFECTS OF CANNABIS SATIVA AND THEIR MODULATION BY ANTIDEPRESSANT DRUGS

  2013cites this paper
• Endocannabinoid system and mood disorders: priming a target for new therapies.

  2013cites this paper
• Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.

  2013cites this paper
• Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors

  2013cites this paper
• Endocannabinoids, Monoamines and Stress

  2013cites this paper
• Neuronal populations mediating the effects of endocannabinoids on stress and emotionality.

  2012cites this paper
• Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission.

  2012cites this paper
• Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral‐Antagonist/Inverse‐Agonist Therapies

  2011cites this paper
• Brain CB2 Receptors: Implications for Neuropsychiatric Disorders

  2010cites this paper
• Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.

  2010cites this paper
• Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

  2010cites this paper
• Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress.

  2009cites this paper
• Altered CB1 receptor‐signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine

  2009cites this paper
• Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity.

  2009cites this paper
• Influence of Sex and CRF Pathways as Determinants in 5-HT Sensitivity Abbreviated title: Sex and Stress in 5-HT Sensitivity

  2009cites this paper
• Endocannabinoids in the treatment of mood disorders: evidence from animal models.

  2009cites this paper